• Kyodo

  • SHARE

Japanese Nobel Prize winner Shinya Yamanaka says he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem (iPS) cells in regenerative medicine.

“I want to use artificial intelligence to analyze the enormous amount of data on the human genome and assess the safety (of the cells) in an objective manner and without oversight,” Yamanaka said in a recent interview.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)